The purpose of this study is to determine the safety and engraftment of donor hematopoietic
cells using this conditioning regimen in patients undergoing a hematopoietic (blood forming)
cell transplant for Hurler syndrome, Maroteaux Lamy syndrome, Mannosidosis, or I-cell
disease.